The Inhibitor of Cap-Dependent Translation 4E-BP1 as a Crossroad between Somatostatin Analogs and Everolimus: Mechanisms and Consequences on Combined Antitumoral Action of Both Drugs
Souad Najib(Hôpital Rangueil), Corinne Bousquet(Centre National de la Recherche Scientifique), Christiane Susini(Inserm), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Laure Guitton-Sert(Centre de Recherche en Cancérologie de Toulouse), Nathalie Saint‐Laurent(Centre National de la Recherche Scientifique), Herbert Schmid(Novartis (Switzerland)), Daniel Fourmy(Inserm), Cathy Marboeuf
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284